Stock Analysis on Net
Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

$24.99

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Paying user area

Try for free

Pfizer Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Pfizer Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income before allocation to noncontrolling interests
Foreign currency translation adjustments, net
Reclassification adjustments
Foreign currency translation adjustments
Unrealized holding gains (losses) on derivative financial instruments, net
Reclassification adjustments for (gains) losses included in net income
Derivative financial instruments
Unrealized holding gains (losses) on available-for-sale securities, net
Reclassification adjustments for (gains) losses included in net income
Available-for-sale securities
Actuarial gains (losses), net
Reclassification adjustments related to amortization
Reclassification adjustments related to settlements, net
Other
Actuarial gains (losses)
Prior service (costs) credits and other, net
Reclassification adjustments related to amortization of prior service costs and other, net
Reclassification adjustments related to curtailments of prior service costs and other, net
Other
Prior service (costs) credits and other
Benefit plans
Other comprehensive income (loss) before allocation to noncontrolling interests
Comprehensive income before allocation to noncontrolling interests
Comprehensive income attributable to noncontrolling interests
Comprehensive income attributable to Pfizer Inc.

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Comprehensive income item Description The company
Net income attributable to Pfizer Inc. common shareholders The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc. net income attributable to Pfizer Inc. common shareholders decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Comprehensive income attributable to Pfizer Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Pfizer Inc. comprehensive income attributable to Pfizer Inc. decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.